Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling

Experimental Hematology

Volumn 42, Issue 6, 2014, Pages

  Sangkhae, Veena ^a   Saur, Sebastian Jonas ^b   Kaushansky, Alexis ^c   Kaushansky, Kenneth ^a   Hitchcock, Ian Stuart ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CELLULAR MYELOPROLIFERATIVE LEUKEMIA PROTEIN; CYTOKINE RECEPTOR; HEMOPOIETIC GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLALANINE; PROTEIN KINASE SYK; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE SHP 1; SMALL INTERFERING RNA; THROMBOPOIETIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; THROMBOPOIETIN; TYROSINE;

EID: 84902654969     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.02.007     Document Type: Article

References (35)

1. Drachman J.G., Griffin J.D., Kaushansky K. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. JBiol Chem 1995, 270:4979-4982.
2. de Sauvage F.J., Hass P.E., Spencer S.D., et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994, 369:533-538.
3. Royer Y., Staerk J., Costuleanu M., Courtoy P.J., Constantinescu S.N. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem 2005, 280:27251-27261.
4. Parganas E., Wang D., Stravopodis D., et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998, 93:385-395.
5. Kaushansky K., Drachman J.G. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002, 21:3359-3367.
6. Alexander W.S., Metcalf D., Dunn A.R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 1995, 14:5569-5578.
7. Drachman J.G., Kaushansky K. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci U S A 1997, 94:2350-2355.
8. Rojnuckarin P., Drachman J.G., Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 1999, 94:1273-1282.
9. Miyakawa Y., Rojnuckarin P., Habib T., Kaushansky K. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem 2001, 276:2494-2502.
10. Hong Y., Dumenil D., van der Loo B., Goncalves F., Vainchenker W., Erusalimsky J.D. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells. Blood 1998, 91:813-822.
11. Drachman J.G., Sabath D.F., Fox N.E., Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 1997, 89:483-492.
12. Bouscary D., Lecoq-Lafon C., Chretien S., et al. Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene 2001, 20:2197-2204.
13. Kaushansky K. On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 2005, 105:4187-4190.
14. Pikman Y., Lee B.H., Mercher T., et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 2006, 3:e270.
15. Pardanani A.D., Levine R.L., Lasho T., et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006, 108:3472-3476.
16. Ding J., Komatsu H., Wakita A., et al. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 2004, 103:4198-4200.
17. Wang Q., Miyakawa Y., Fox N., Kaushansky K. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 2000, 96:2093-2099.
18. Tong W., Lodish H.E. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004, 200:569-580.
19. Lannutti B.J., Minear J., Blake N., Drachman J.G. Increased megakaryocytopoiesis in Lyn-deficient mice. Oncogene 2006, 25:3316-3324.
20. Hitchcock I.S., Chen M.M., King J.R., Kaushansky K. YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation. Blood 2008, 112:2222-2231.
21. Saur S.J., Sangkhae V., Geddis A.E., Kaushansky K., Hitchcock I.S. Ubiquitination and degradation of the thrombopoietin receptor c-Mpl. Blood 2010, 115:1254-1263.
22. Pecquet C., Staerk J., Chaligne R., et al. Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor. Blood 2010, 115:1037-1048.
23. Chiba S., Takaku F., Tange T., et al. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 1991, 78:2261-2268.
24. Kaushansky A., Allen J.E., Gordus A., et al. Quantifying protein-protein interactions in high throughput using protein domain microarrays. Nat Protoc 2010, 5:773-790.
25. Jung A.S., Kaushansky A., Macbeath G., Kaushansky K. Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling. Cell Cycle 2011, 10:1838-1844.
26. Ohno H., Stewart J., Fournier M.C., et al. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995, 269:1872-1875.
27. Simon M., Vanes L., Geahlen R.L., Tybulewicz V.L. Distinct roles for the linker region tyrosines of Syk in FcepsilonRI signaling in primary mast cells. J Biol Chem 2005, 280:4510-4517.
28. Matsumura I., Nakajima K., Wakao H., et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol 1998, 18:4282-4290.
29. Kaushansky K. Thrombopoietin and the hematopoietic stem cell. Ann N Y Acad Sci 2005, 1044:139-141.
30. Ward A.F., Braun B.S., Shannon K.M. Targeting oncogenic Ras signaling in hematologic malignancies. Blood 2012, 120:3397-3406.
31. Mocsai A., Ruland J., Tybulewicz V.L. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 2010, 10:387-402.
32. Ruschel A., Ullrich A. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells. Cell Signal 2004, 16:1249-1261.
33. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995, 80:729-738.
34. Sharlow E.R., Pacifici R., Crouse J., Batac J., Todokoro K., Wojchowski D.M. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells. Blood 1997, 90:2175-2187.
35. Kawamata N., Ogawa S., Yamamoto G., et al. Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray. Exp Hematol 2008, 36:1471-1479.